These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 39382996)

  • 21. Single-Molecule Sequencing Enables Long Cell-Free DNA Detection and Direct Methylation Analysis for Cancer Patients.
    Choy LYL; Peng W; Jiang P; Cheng SH; Yu SCY; Shang H; Olivia Tse OY; Wong J; Wong VWS; Wong GLH; Lam WKJ; Chan SL; Chiu RWK; Chan KCA; Lo YMD
    Clin Chem; 2022 Sep; 68(9):1151-1163. PubMed ID: 35587130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The fragmentation patterns of maternal plasma cell-free DNA and its applications in non-invasive prenatal testing.
    Pan M; Chen P; Lu J; Liu Z; Jia E; Ge Q
    Prenat Diagn; 2020 Jul; 40(8):911-917. PubMed ID: 32147843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments.
    Sun K; Jiang P; Chan KC; Wong J; Cheng YK; Liang RH; Chan WK; Ma ES; Chan SL; Cheng SH; Chan RW; Tong YK; Ng SS; Wong RS; Hui DS; Leung TN; Leung TY; Lai PB; Chiu RW; Lo YM
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):E5503-12. PubMed ID: 26392541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatic Mutations in Circulating Cell-Free DNA and Risk for Hepatocellular Carcinoma in Hispanics.
    Jiao J; Sanchez JI; Thompson EJ; Mao X; McCormick JB; Fisher-Hoch SP; Futreal PA; Zhang J; Beretta L
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidimensional Fragmentomics Enables Early and Accurate Detection of Colorectal Cancer.
    Cao Y; Wang N; Wu X; Tang W; Bao H; Si C; Shao P; Li D; Zhou X; Zhu D; Yang S; Wang F; Su G; Wang K; Wang Q; Zhang Y; Wang Q; Yu D; Jiang Q; Bao J; Yang L
    Cancer Res; 2024 Oct; 84(19):3286-3295. PubMed ID: 39073362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigating crosstalk between H3K27 acetylation and H3K4 trimethylation in CRISPR/dCas-based epigenome editing and gene activation.
    Zhao W; Xu Y; Wang Y; Gao D; King J; Xu Y; Liang FS
    Sci Rep; 2021 Aug; 11(1):15912. PubMed ID: 34354157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma.
    Cai J; Chen L; Zhang Z; Zhang X; Lu X; Liu W; Shi G; Ge Y; Gao P; Yang Y; Ke A; Xiao L; Dong R; Zhu Y; Yang X; Wang J; Zhu T; Yang D; Huang X; Sui C; Qiu S; Shen F; Sun H; Zhou W; Zhou J; Nie J; Zeng C; Stroup EK; Zhang X; Chiu BC; Lau WY; He C; Wang H; Zhang W; Fan J
    Gut; 2019 Dec; 68(12):2195-2205. PubMed ID: 31358576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-modal cell-free DNA genomic and fragmentomic patterns enhance cancer survival and recurrence analysis.
    Moldovan N; van der Pol Y; van den Ende T; Boers D; Verkuijlen S; Creemers A; Ramaker J; Vu T; Bootsma S; Lenos KJ; Vermeulen L; Fransen MF; Pegtel M; Bahce I; van Laarhoven H; Mouliere F
    Cell Rep Med; 2024 Jan; 5(1):101349. PubMed ID: 38128532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromatin- and nucleosome-associated features in liquid biopsy: implications for cancer biomarker discovery.
    Penny L; Main SC; De Michino SD; Bratman SV
    Biochem Cell Biol; 2024 Aug; 102(4):291-298. PubMed ID: 38478957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Landscape of Cell-Free HBV Integrations and Mutations in Cirrhosis and Hepatocellular Carcinoma Patients.
    Zheng B; Liu XL; Fan R; Bai J; Wen H; Du LT; Jiang GQ; Wang CY; Fan XT; Ye YN; Qian YS; Wang YC; Liu GJ; Deng GH; Shen F; Hu HP; Wang H; Zhang QZ; Ru LL; Zhang J; Gao YH; Xia J; Yan HD; Liang MF; Yu YL; Sun FM; Gao YJ; Sun J; Zhong CX; Wang Y; Kong F; Chen JM; Zheng D; Yang Y; Wang CX; Wu L; Hou JL; Liu JF; Wang HY; Chen L
    Clin Cancer Res; 2021 Jul; 27(13):3772-3783. PubMed ID: 33947693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial.
    Alunni-Fabbroni M; Rönsch K; Huber T; Cyran CC; Seidensticker M; Mayerle J; Pech M; Basu B; Verslype C; Benckert J; Malfertheiner P; Ricke J
    J Transl Med; 2019 Oct; 17(1):328. PubMed ID: 31570105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma Cell-Free DNA as a Predictive Marker after Radiotherapy for Hepatocellular Carcinoma.
    Park S; Lee EJ; Rim CH; Seong J
    Yonsei Med J; 2018 Jun; 59(4):470-479. PubMed ID: 29749129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating nuclear DNA structural features, origins, and complete size profile revealed by fragmentomics.
    Sanchez C; Roch B; Mazard T; Blache P; Dache ZAA; Pastor B; Pisareva E; Tanos R; Thierry AR
    JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33571170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications.
    Zhang C; Li H; Wang Y; Liu W; Zhang Q; Zhang T; Zhang X; Han B; Zhou G
    J Hepatol; 2010 Nov; 53(5):889-95. PubMed ID: 20675009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of Preanalytical and Physiological Variables on Cell-Free DNA Fragmentation.
    van der Pol Y; Moldovan N; Verkuijlen S; Ramaker J; Boers D; Onstenk W; de Rooij J; Bahce I; Pegtel DM; Mouliere F
    Clin Chem; 2022 Jun; 68(6):803-813. PubMed ID: 35292813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent activation of acetylation and tri-methylation of H3K27 in a subset of hepatocellular carcinoma with aggressive behavior.
    Hayashi A; Yamauchi N; Shibahara J; Kimura H; Morikawa T; Ishikawa S; Nagae G; Nishi A; Sakamoto Y; Kokudo N; Aburatani H; Fukayama M
    PLoS One; 2014; 9(3):e91330. PubMed ID: 24614346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-time analysis of the cancer genome and fragmentome from plasma and urine cell-free DNA using nanopore sequencing.
    van der Pol Y; Tantyo NA; Evander N; Hentschel AE; Wever BM; Ramaker J; Bootsma S; Fransen MF; Lenos KJ; Vermeulen L; Schneiders FL; Bahce I; Nieuwenhuijzen JA; Steenbergen RD; Pegtel DM; Moldovan N; Mouliere F
    EMBO Mol Med; 2023 Dec; 15(12):e17282. PubMed ID: 37942753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methylation-Associated Nucleosomal Patterns of Cell-Free DNA in Cancer Patients and Pregnant Women.
    Zhu G; Jiang P; Li X; Peng W; Choy LYL; Yu SCY; Zhou Q; Ma ML; Kang G; Bai J; Qiao R; Deng CXS; Ding SC; Lam WKJ; Chan SL; Lau SL; Leung TY; Wong J; Chan KCA; Lo YMD
    Clin Chem; 2024 Aug; ():. PubMed ID: 39206580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fragment Ends of Circulating Microbial DNA as Signatures for Pathogen Detection in Sepsis.
    Wang G; Lam WKJ; Ling L; Ma ML; Ramakrishnan S; Chan DCT; Lee WS; Cheng SH; Chan RWY; Yu SCY; Tse IOL; Wong WT; Jiang P; Chiu RWK; Allen Chan KC; Lo YMD
    Clin Chem; 2023 Feb; 69(2):189-201. PubMed ID: 36576350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic performance of circulating cell-free DNA for hepatocellular carcinoma: a systematic review and meta-analysis.
    Zhang J; Yuan Y; Gao S; Zhao X; Li H
    Biomark Med; 2021 Feb; 15(3):219-239. PubMed ID: 33470842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.